We are pleased to announce that there is an open spot for a virtual TACT (TREAT-NMD Advisory Committee for Therapeutics) review on Tuesday, July 29th, 2025. This is a unique opportunity for individuals or organizations seeking expert feedback on drug development and treatment strategies in the field of neuromuscular diseases.
The TACT is a multi-disciplinary group of international experts, including academic and industry drug development specialists, patient foundation representatives, and regulatory bodies. The committee evaluates the therapeutic potential of drugs across a broad spectrum of neuromuscular diseases, such as acquired and genetic motor neuron disorders, neuromuscular junction diseases, peripheral nerve diseases, and muscle diseases.
TACT’s goal is to provide a comprehensive, confidential review with constructive feedback and guidance, based on years of experience. This review aims to optimize drug design and development programs, helping to drive more effective treatments for those living with neuromuscular conditions.
Applications are now open! If you’re interested in participating, please email ella.vickers@treat-nmd.com and laure.robertson@treat-nmd.com for inquiries or to apply for a spot.
